尾原　秀明 （オバラ　ヒデアキ）

Obara, Hideaki

写真a

所属（所属キャンパス）

医学部 外科学教室（一般・消化器） （信濃町）

職名

准教授

HP

外部リンク
このページの先頭へ▲

その他の所属・職名 【 表示 ／ 非表示 】

  • 医学部, 感染対策室, 副センター長

このページの先頭へ▲

経歴 【 表示 ／ 非表示 】

  • 2012年10月
    -
    2016年06月

    慶應義塾大学, 外科, 専任講師

このページの先頭へ▲

学歴 【 表示 ／ 非表示 】

  • 1993年03月

    慶應義塾大学医学部

    大学, 卒業

このページの先頭へ▲

学位 【 表示 ／ 非表示 】

  • 医学博士, 慶應義塾大学, 大学評価・学位授与機構, 2001年07月

    Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.

このページの先頭へ▲
 

研究分野 【 表示 ／ 非表示 】

  • ライフサイエンス / 外科学一般、小児外科学

このページの先頭へ▲

研究キーワード 【 表示 ／ 非表示 】

  • 血管再生

このページの先頭へ▲

研究テーマ 【 表示 ／ 非表示 】

  • 血管内留置生体吸収性ステントの開発と実用化, 

    2011年01月
    -
    継続中

このページの先頭へ▲
 

論文 【 表示 ／ 非表示 】

  • Long-term outcomes of living donor liver transplantation after locoregional treatment for hepatocellular carcinoma: an experience from a single institute

    Inomata K., Yagi H., Hibi T., Shinoda M., Matsubara K., Abe Y., Kitago M., Obara H., Itano O., Kawachi S., Tanabe M., Wakabayashi G., Shimazu M., Kitagawa Y.

    Surgery Today （Surgery Today）  51 （ 3 ） 350 - 357 2021年03月

    ISSN  09411291

    　概要を見る

    Purpose: The precise role of downstaging or bridge therapy for cirrhotic patients with hepatocellular carcinoma (HCC) beyond or within the Milan criteria (MC) before living donor liver transplantation (LDLT) remains undefined. Methods: We conducted a single-center, retrospective cohort study of 40 cirrhotic patients with HCC who underwent LDLT from 2000 to 2018. Dynamic computed tomography images at the initial presentation and immediately before LDLT as well as the final histopathological findings were reviewed to determine whether they met or exceeded MC. Results: Overall, 29 patients underwent various pre-transplant HCC treatments, including ablation and embolization (bridge therapy, n = 20; downstaging, n = 9). Of the 9 patients who were initially beyond the MC, 4 (44.4%) were successfully downstaged to within the MC. Five patients beyond the MC immediately before LDLT demonstrated a significantly worse 5-year overall survival rate than patients within the MC (16.7% vs. 82.2%, P = 0.004), regardless of the radiological HCC stage at presentation or the final pathological tumor status. All 3 recurrent patients had HCC beyond the MC immediately before transplant and died of their disease at 13, 24, and 50 months after transplantation. Conclusions: Successful downstaging for HCC cases beyond the MC provides similar outcomes to those within the MC at presentation, regardless of the histopathological findings.

  • CT screening for COVID-19 in asymptomatic patients before hospital admission

    Uchida S., Uno S., Uwamino Y., Hashimoto M., Matsumoto S., Obara H., Jinzaki M., Kitagawa Y., Hasegawa N.

    Journal of Infection and Chemotherapy （Journal of Infection and Chemotherapy）  27 （ 2 ） 232 - 236 2021年02月

    ISSN  1341321X

    　概要を見る

    Introduction: In the novel coronavirus disease (COVID-19) pandemic era, it is essential to rule out COVID-19 effectively to prevent transmission in both communities and medical facilities. According to previous reports in high prevalence areas, CT screening may be useful in the diagnosis of COVID-19. However, the value of CT screening in low prevalence areas has scarcely been reported. Methods: This report examines the diagnostic efficacy of CT screening before admission to a hospital in Tokyo. We conducted a retrospective analysis at Keio University Hospital from April 6, 2020, through May 29, 2020. We set up an outpatient screening clinic on April 6 for COVID-19, administering both PCR with nasopharyngeal swabs and chest CT for all patients scheduled for surgery under general anesthesia. Results: A total of 292 asymptomatic patients were included in this study. There were three PCR-positive patients, and they all had negative CT findings, which revealed that both the sensitivity and positive predictive value of CT (PPV) were 0%. There were nine CT-positive patients; the specificity and the negative predictive value (NPV) were 96.9% and 98.9%, respectively. Conclusion: CT screening was not useful in low prevalence areas at this time in Tokyo, even with the inclusion of the most prevalent phase. Given that the utility of CT screening depends on disease prevalence, the criteria for performing CT screening based on the prevalence of COVID-19 should be established.

  • In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas

    Janko M.R., Woo K., Hacker R.I., Baril D., Bath J., Smeds M.R., Kashyap V.S., Szeberin Z., Magee G.A., Elsayed R., Wishy A., St. John R., Beck A., Farber M., Motta F., Zhou W., Lemmon G., Coleman D., Behrendt C.A., Aziz F., Black J., Shutze W., Garrett H.E., De Caridi G., Liapis C.D., Geroulakos G., Kakisis J., Moulakakis K., Kakkos S.K., Obara H., Wang G., Rhéaume P., Davila V., Ravin R., DeMartino R., Milner R., Shalhub S., Jim J., Lee J., Dubuis C., Ricco J.B., Coselli J., Lemaire S., Fatima J., Sanford J., Yoshida W., Schermerhorn M.L., Menard M., Belkin M., Blackwood S., Conrad M., Wang L., Crofts S., Nixon T., Wu T., Chiesa R., Bose S., Turner J., Moore R., Smith J., Ciocca R., Hsu J., Czerny M., Cullen J., Kahlberg A., Setacci C., Joh J.H., Senneville E., Garrido P., Sarac T.P., Rizzo A., Go M.R., Bjorck M., Gavali H., Wanhainen A., Lawrence P.F., Chung J.

    Journal of Vascular Surgery （Journal of Vascular Surgery）  73 （ 1 ） 210 - 221.e1 2021年01月

    ISSN  07415214

    　概要を見る

    Objective: The optimal revascularization modality in secondary aortoenteric fistula (SAEF) remains unclear in the literature. The purpose of this investigation was to determine the revascularization approach associated with the lowest morbidity and mortality using real-world data in patients with SAEF. Methods: A retrospective, multi-institutional study of SAEF from 2002 to 2014 was performed using a standardized database. Baseline demographics, comorbidities, and operative and postoperative variables were recorded. The primary outcome was long-term mortality. Descriptive statistics, Kaplan-Meier survival analysis, and univariate and multivariate analyses were performed. Results: During the study period, 182 patients at 34 institutions from 11 countries presented with SAEF (median age, 72 years; 79% male). The initial aortic procedures that resulted in SAEF were 138 surgical grafts (76%) and 42 endografts (23%), with 2 unknown; 102 of the SAEFs (56%) underwent complete excision of infected aortic graft material, followed by in situ (in-line) bypass (ISB), including antibiotic-soaked prosthetic graft (53), autogenous femoral vein (neoaortoiliac surgery; 17), cryopreserved allograft (28), and untreated prosthetic grafts (4). There were 80 patients (44%) who underwent extra-anatomic bypass (EAB) with infected graft excision. Overall median Kaplan-Meier estimated survival was 319 days (interquartile range, 20-2410 days). Stratified by EAB vs ISB, there was no significant difference in Kaplan-Meier estimated survival (P =.82). In comparing EAB vs ISB, EAB patients were older (74 vs 70 years; P =.01), had less operative hemorrhage (1200 mL vs 2000 mL; P =.04), were more likely to initiate dialysis within 30 days postoperatively (15% vs 5%; P =.02), and were less likely to experience aorta-related hemorrhage within 30 days postoperatively (3% aortic stump dehiscence vs 11% anastomotic rupture; P =.03). There were otherwise no significant differences in presentation, comorbidities, and intraoperative or postoperative variables. Multivariable Cox regression showed that the duration of antibiotic use (hazard ratio, 0.92; 95% confidence interval, 0.86-0.98; P =.01) and rifampin use at time of discharge (hazard ratio, 0.20; 95% confidence interval, 0.05-0.86; P =.03) independently decreased mortality. Conclusions: These data suggest that ISB does not offer a survival advantage compared with EAB and does not decrease the risk of postoperative aorta-related hemorrhage. After repair, <50% of SAEF patients survive 10 months. Each week of antibiotic use decreases mortality by 8%. Further study with risk modeling is imperative for this population.

  • Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature

    Abe K., Shinoda M., Uno S., Obara H., Kitago M., Abe Y., Hishida T., Yagi H., Hasegawa Y., Kitagawa Y.

    Surgery Today （Surgery Today）  2021年

    ISSN  09411291

    　概要を見る

    Purpose: Invasive pulmonary aspergillosis (IPA) after liver transplantation (LT) is most often fatal. We analyzed the outcomes of IPA in a single center. Methods: We reviewed, retrospectively, the medical records of recipients of living donor LT (LDLT) or deceased donor LT (DDLT) performed between 1995 and 2019 at our institute. We analyzed the incidence of IPA and assessed the treatment courses of patients treated successfully and those not treatment successfully. Results: Among 326 recipients, IPA was diagnosed in 6 (1.8%). The incidence of IPA was significantly higher in patients with acute liver failure (ALF, 9.8%) than in those without ALF (0.4%), after DDLT (8.8%) than after LDLT (1.0%), and in recipients who received preoperative steroid pulse therapy (16.0%) than in those who did not (0.7%). Complete cure of IPA was achieved in the most recent three patients, by administering voriconazole immediately after the diagnosis of IPA and performing lung resection, while the IPA lesion was single and localized. Conclusions: Patients with risk factors for IPA must be monitored closely. Our three successfully treated cases demonstrate that initiating immediate voriconazole treatment and making a calculated decision about lung resection can contribute to a favorable outcome.

  • Clinical features of irreversible rejection after allogeneic uterus transplantation in cynomolgus macaques

    Kisu I., Emoto K., Masugi Y., Yamada Y., Matsubara K., Obara H., Matoba Y., Banno K., Kato Y., Saiki Y., Itagaki I., Kawamoto I., Iwatani C., Murase M., Nakagawa T., Tsuchiya H., Ishigaki H., Urano H., Ema M., Ogasawara K., Aoki D., Nakagawa K., Shiina T.

    Scientific Reports （Scientific Reports）  10 （ 1 ）  2020年12月

    　概要を見る

    Uterus transplantation (UTx) is a potential option for women with uterine factor infertility to have a child. The clinical features indicating irreversible rejection of the uterus are unknown. In our experimental series of allogeneic UTx in cynomolgus macaques, six female macaques were retrospectively examined, which were unresponsive to treatment with immunosuppressants (i.e. irreversible rejection). Clinical features including general condition, hematology, uterine size, indocyanine green (ICG) fluorescence imaging by laparotomy, and histopathological findings of the removed uterus were evaluated. In all cases, general condition was good at the time of diagnosis of irreversible rejection and thereafter. Laboratory evaluation showed temporary increases in white blood cells, lactate dehydrogenase and C-reactive protein, then these levels tended to decrease gradually. In transabdominal ultrasonography, the uterus showed time-dependent shrinkage after transient swelling at the time of diagnosis of irreversible rejection. In laparotomy, a whitish transplanted uterus was observed and enhancement of the transplanted uterus was absent in ICG fluorescence imaging. Histopathological findings in each removed uterus showed hyalinized fibrosis, endometrial deficit, lymphocytic infiltration and vasculitis. These findings suggest that uterine transplantation rejection is not fatal, in contrast to rejection of life-supporting organs. Since the transplanted uterus with irreversible rejection atrophies naturally, hysterectomy may be unnecessary.

全件表示 >>

このページの先頭へ▲

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

全件表示 >>

このページの先頭へ▲

総説・解説等 【 表示 ／ 非表示 】

  • Correction to: Current management strategies for visceral artery aneurysms: an overview (Surgery Today, (2020), 50, 1, (38-49), 10.1007/s00595-019-01898-3)

    Obara H., Kentaro M., Inoue M., Kitagawa Y.

    Surgery Today （Surgery Today）  50 （ 3 ）  2020年03月

    ISSN  09411291

    　概要を見る

    The article Current management strategies for visceral artery aneurysms: an overview, written by Hideaki Obara, Matsubara Kentaro, Masanori Inoue and Yuko Kitagawa, was originally published Online First without Open Access. After publication in volume 50, issue 1, pages 38–49 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (https :// creat iveco mmons .org/licen ses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.

  • Emerging problems in uterus transplantation

    Kisu I., Kato Y., Obara H., Matsubara K., Matoba Y., Banno K., Aoki D.

    BJOG: An International Journal of Obstetrics and Gynaecology （BJOG: An International Journal of Obstetrics and Gynaecology）  125 （ 11 ） 1352 - 1356 2018年10月

    ISSN  14700328

  • Progressive mycotic celiac artery aneurysm associated with coagulase-negative staphylococcal prosthetic valve endocarditis

    Tanaka M., Kohno T., Obara H., Nakatsuka S., Nishiyama T., Nishiyama N., Tsuruta H., Murata M., Maekawa Y., Yoshitake A., Sano M., Shimizu H., Fukuda K.

    Circulation Journal （Circulation Journal）  82 （ 7 ） 1965 - 1967 2018年

    ISSN  13469843

このページの先頭へ▲

競争的研究費の研究課題 【 表示 ／ 非表示 】

  • 間葉系幹細胞/間質細胞株（ASCL）による肝虚血再灌流障害の抑制と肝移植への応用

    2020年04月
    -
    2023年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 尾原 秀明, 基盤研究(C), 補助金,  研究代表者

  • 肝虚血再灌流障害抑制/抗血小板作用を持つ薬剤溶出生体吸収ステント開発と肝移植応用

    2015年04月
    -
    2018年03月

    文部科学省・日本学術振興会, 科学研究費助成事業, 尾原　秀明, 基盤研究(C), 補助金,  研究代表者

このページの先頭へ▲
 

担当授業科目 【 表示 ／ 非表示 】

  • 急性期病態学各論

    2024年度

  • 外科学講義

    2024年度

  • 急性期病態学各論

    2023年度

  • 外科学講義

    2023年度

  • 感染症学

    2023年度

全件表示 >>

このページの先頭へ▲